autosomal dominant polycystic kidney disease therapeutics

Autosomal dominant polycystic kidney disease(Maze Therapeutics)

autosomal dominant polycystic kidney disease therapy, Healx

Autosomal dominant retinitis pigmentosa (Applied Genetic Technologies)

gene therapy (AAVANc, autosomal dominant hearing loss)

PD-1 dominant negative TurboCAR T cells (solid tumors)

small molecule therapeutic (oral, RHO-associated autosomal dominant retinitis pigmentosa)

Pan-HER ACL

next gen ACLY inhibitor (autosomal dominant polycystic kidney disease/chronic kidney disease)

Tolvaptan(Jinarc, Jynarque 45/15 Carton, Samsca, Tolvaptan Accord)

C₂₆H₂₅ClN₂O₃